{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:09:16Z","timestamp":1791994156082,"version":"4.4.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18063889"],"award-info":[{"award-number":["18063889"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["16H06391"],"award-info":[{"award-number":["16H06391"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["22K16323"],"award-info":[{"award-number":["22K16323"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","award":["23K07816"],"award-info":[{"award-number":["23K07816"]}],"id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018289","name":"Shinnihon Foundation of Advanced Medical Treatment Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H00540"],"award-info":[{"award-number":["20H00540"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H01567"],"award-info":[{"award-number":["17H01567"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H05699"],"award-info":[{"award-number":["20H05699"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008880","name":"Kanae Foundation for the Promotion of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013236","name":"MSD Life Science Foundation, Public Interest Incorporated Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008673","name":"Yasuda Memorial Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bneo.2024.100015","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T06:10:27Z","timestamp":1714457427000},"page":"100015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1012-2311","authenticated-orcid":false,"given":"Hiroshi","family":"Imanaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8576-3530","authenticated-orcid":false,"given":"Yuichiro","family":"Semba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5303-6240","authenticated-orcid":false,"given":"Kiyoko","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary","family":"Maniriho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-9939","authenticated-orcid":false,"given":"Tatsuya","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-2540","authenticated-orcid":false,"given":"Shai","family":"Izraeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-6460","authenticated-orcid":false,"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bneo.2024.100015_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01","volume":"97","author":"Silverman","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.bneo.2024.100015_bib3","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10230","key":"10.1016\/j.bneo.2024.100015_bib4","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"issue":"8764","key":"10.1016\/j.bneo.2024.100015_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0140-6736(91)91029-T","article-title":"Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia","volume":"338","author":"Pieters","year":"1991","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.bneo.2024.100015_bib6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1182\/blood.V94.4.1209","article-title":"Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia","volume":"94","author":"D\u00f6rdelmann","year":"1999","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bneo.2024.100015_bib7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.leu.2402144","article-title":"Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in\u00a0vitro prednisolone resistance","volume":"15","author":"Schmiegelow","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bneo.2024.100015_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s43018-020-0037-3","article-title":"Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia","author":"Autry","year":"2020","journal-title":"Nature Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41591-022-02112-7","article-title":"Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response","volume":"29","author":"Lee","year":"2023","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.bneo.2024.100015_bib10","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood.V86.10.3861.bloodjournal86103861","article-title":"In\u00a0vitro cellular drug resistance in children with relapsed\/refractory acute lymphoblastic leukemia","volume":"86","author":"Klumper","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcp.1040980203","article-title":"Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line","volume":"98","author":"Harmon","year":"1979","journal-title":"J\u00a0Cell Physiol"},{"issue":"5756","key":"10.1016\/j.bneo.2024.100015_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/284555a0","article-title":"Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation","volume":"284","author":"Wyllie","year":"1980","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bneo.2024.100015_bib13","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1074\/jbc.C000526200","article-title":"Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-\u03baB and induction of apoptosis","volume":"276","author":"Tao","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"13","key":"10.1016\/j.bneo.2024.100015_bib14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.onc.1209218","article-title":"Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.bneo.2024.100015_bib15","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1182\/blood-2006-11-056366","article-title":"Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells","volume":"109","author":"Tissing","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bneo.2024.100015_bib16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","article-title":"Glucocorticoid use in acute lymphoblastic leukaemia","volume":"11","author":"Inaba","year":"2010","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.bneo.2024.100015_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.89","article-title":"Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells","volume":"3","author":"Heidari","year":"2012","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2014-05-576470","article-title":"Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells","volume":"125","author":"Jing","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188430","article-title":"Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies","volume":"1874","author":"Clarisse","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2024.100015_bib20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41419-020-2599-5","article-title":"Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.bneo.2024.100015_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.2021012976","article-title":"Genome-wide CRISPR-Cas9 screen identifies rationally designed combination therapies for CRLF2-rearranged Ph-like ALL","volume":"139","author":"Sasaki","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.bneo.2024.100015_bib23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ccell.2018.01.012","article-title":"Genome-wide CRISPR-Cas9 screen identifies leukemia-specific dependence on a pre-mRNA metabolic pathway regulated by DCPS","volume":"33","author":"Yamauchi","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41375-021-01369-0","article-title":"Targeting leukemia-specific dependence on the de novo purine synthesis pathway","volume":"36","author":"Yamauchi","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bneo.2024.100015_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-023-01879-z","article-title":"Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance","author":"Nakao","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.bneo.2024.100015_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13059-015-0843-6","article-title":"Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR","volume":"16","author":"Li","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.bneo.2024.100015_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ebiom.2016.06.001","article-title":"Deciphering \"B-others\": novel fusion genes driving B-cell acute lymphoblastic leukemia","volume":"8","author":"Izraeli","year":"2016","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-019-0665-3","article-title":"Identifying chemogenetic interactions from CRISPR screens with drugZ","volume":"11","author":"Colic","year":"2019","journal-title":"Genome Med"},{"issue":"52","key":"10.1016\/j.bneo.2024.100015_bib29","doi-asserted-by":"crossref","first-page":"35194","DOI":"10.1074\/jbc.273.52.35194","article-title":"Hop as an adaptor in the heat shock protein 70 (Hsp70) and hsp90 chaperone machinery","volume":"273","author":"Chen","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"22","key":"10.1016\/j.bneo.2024.100015_bib30","doi-asserted-by":"crossref","first-page":"12833","DOI":"10.1074\/jbc.271.22.12833","article-title":"Reconstitution of the steroid receptor\u00b7hsp90 heterocomplex assembly system of rabbit reticulocyte lysate","volume":"271","author":"Dittmar","year":"1996","journal-title":"J\u00a0Biol Chem"},{"issue":"30","key":"10.1016\/j.bneo.2024.100015_bib31","doi-asserted-by":"crossref","first-page":"20502","DOI":"10.1074\/jbc.M114.569889","article-title":"Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model","volume":"289","author":"Jones","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"11","key":"10.1016\/j.bneo.2024.100015_bib32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tem.2021.08.003","article-title":"FKBP51 and the molecular chaperoning of metabolism","volume":"32","author":"Smedlund","year":"2021","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.bneo.2024.100015_bib33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"issue":"15","key":"10.1016\/j.bneo.2024.100015_bib34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev"},{"issue":"6514","key":"10.1016\/j.bneo.2024.100015_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1126\/science.aaz0863","article-title":"The GATOR-Rag GTPase pathway inhibits mTORC1 activation by lysosome-derived amino acids","volume":"370","author":"Hesketh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bneo.2024.100015_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.673213","article-title":"Efficacy of a novel bi-steric mTORC1 inhibitor in models of B-cell acute lymphoblastic leukemia","volume":"11","author":"Lee","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bneo.2024.100015_bib37","article-title":"Discovery of RMC-5552, a selective bi-steric inhibitor of mTORC1, for the treatment of mTORC1-activated tumors","author":"Burnett","year":"2022","journal-title":"J\u00a0Med Chem"},{"issue":"4","key":"10.1016\/j.bneo.2024.100015_bib38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cyto.a.22312","article-title":"Use of LysoTracker dyes: a flow cytometric study of autophagy","volume":"85","author":"Chikte","year":"2014","journal-title":"Cytometry"},{"issue":"12","key":"10.1016\/j.bneo.2024.100015_bib41","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1091\/mbc.e08-01-0080","article-title":"Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG","volume":"19","author":"Itakura","year":"2008","journal-title":"Mol Biol Cell"},{"issue":"7","key":"10.1016\/j.bneo.2024.100015_bib42","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4161\/auto.5.7.9296","article-title":"Atg101, a novel mammalian autophagy protein interacting with Atg13","volume":"5","author":"Hosokawa","year":"2009","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.bneo.2024.100015_bib43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4161\/auto.5.5.8249","article-title":"A\u00a0novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy","volume":"5","author":"Mercer","year":"2009","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.bneo.2024.100015_bib44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb1854","article-title":"Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex","volume":"11","author":"Zhong","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib45","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.2019002220","article-title":"Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia","volume":"135","author":"Li","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2024.100015_bib46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1074-7613(00)80398-2","article-title":"A\u00a0new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR\/CD3-activated cell death","volume":"7","author":"D'Adamio","year":"1997","journal-title":"Immunity"},{"issue":"23","key":"10.1016\/j.bneo.2024.100015_bib47","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev"},{"issue":"51","key":"10.1016\/j.bneo.2024.100015_bib48","doi-asserted-by":"crossref","first-page":"39128","DOI":"10.1074\/jbc.M610023200","article-title":"Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1","volume":"281","author":"Wang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"18","key":"10.1016\/j.bneo.2024.100015_bib49","doi-asserted-by":"crossref","DOI":"10.1242\/dev.165324","article-title":"GILZ-dependent modulation of mTORC1 regulates spermatogonial maintenance","volume":"145","author":"La","year":"2018","journal-title":"Development"},{"issue":"9","key":"10.1016\/j.bneo.2024.100015_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2006.09.007","article-title":"Attenuation of leptin and insulin signaling by SOCS proteins","volume":"17","author":"Howard","year":"2006","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","article-title":"The CASTOR proteins are arginine sensors for the mTORC1 pathway","volume":"165","author":"Chantranupong","year":"2016","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.bneo.2024.100015_bib52","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","article-title":"Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"120","author":"Maude","year":"2012","journal-title":"Blood"},{"issue":"37","key":"10.1016\/j.bneo.2024.100015_bib53","doi-asserted-by":"crossref","first-page":"13489","DOI":"10.1073\/pnas.0405659101","article-title":"Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase","volume":"101","author":"Roux","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","article-title":"Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis","volume":"121","author":"Ma","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib55","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1158\/1535-7163.MCT-14-0647","article-title":"Evaluation of the in\u00a0vitro and in\u00a0vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia","volume":"14","author":"Suryani","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood-2016-05-707653","article-title":"Potent efficacy of combined PI3K\/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"129","author":"Tasian","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bneo.2024.100015_bib58","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.18632\/oncotarget.24020","article-title":"mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL","volume":"9","author":"Gotesman","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bneo.2024.100015_bib59","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1172\/JCI134424","article-title":"Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALL","volume":"130","author":"Hurtz","year":"2020","journal-title":"J\u00a0Clin Invest"},{"issue":"7805","key":"10.1016\/j.bneo.2024.100015_bib60","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41586-020-2214-z","article-title":"The mutational landscape of normal human endometrial epithelium","volume":"580","author":"Moore","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bneo.2024.100015_bib61","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjh.14529","article-title":"m-TOR inhibitors and their potential role in haematological malignancies","volume":"177","author":"Calimeri","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bneo.2024.100015_bib62","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"issue":"7606","key":"10.1016\/j.bneo.2024.100015_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature17963","article-title":"Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor","volume":"534","author":"Rodrik-Outmezguine","year":"2016","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.bneo.2024.100015_bib64","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1200\/JCO.2006.07.7792","article-title":"Obesity and outcome in pediatric acute lymphoblastic leukemia","volume":"25","author":"Butturini","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"26","key":"10.1016\/j.bneo.2024.100015_bib65","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2014-08-595389","article-title":"Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia","volume":"124","author":"Orgel","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2024.100015_bib66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.2021011106","article-title":"Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia","volume":"138","author":"Mittelman","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2024.100015_bib67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metabol"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:58:37Z","timestamp":1762657117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328024000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2950328024000153"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100015","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central role of the mTORC1 pathway in glucocorticoid activity against B-ALL cells","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100015"}}